Examples of 'moderate or severe hepatic' in a sentence
Meaning of "moderate or severe hepatic"
moderate or severe hepatic: This phrase pertains to the liver, specifically describing the extent or severity of hepatic (liver-related) conditions. It is commonly used in medical contexts to differentiate between conditions that affect the liver to varying degrees of seriousness, ranging from moderate symptoms to more severe or critical cases
How to use "moderate or severe hepatic" in a sentence
Basic
Advanced
moderate or severe hepatic
Patients with moderate or severe hepatic impairment.
A lower starting dose is recommended in patients with moderate or severe hepatic impairment.
Moderate or severe hepatic impairment.
There are no data in patients with moderate or severe hepatic impairment.
Patients with mild, moderate or severe hepatic impairment may receive the recommended starting dose.
No data are available in patients with moderate or severe hepatic impairment.
No information is available for lorlatinib in patients with moderate or severe hepatic impairment.
There are insufficient data in patients with moderate or severe hepatic impairment for dosing recommendations.
Ribociclib has not been studied in breast cancer patients with moderate or severe hepatic impairment.
Tipranavir is contraindicated in moderate or severe hepatic impairment see sections 4.2 and 4.3.
Abacavir is not recommended in patients with moderate or severe hepatic impairment.
Ranexa is contraindicated in patients with moderate or severe hepatic impairment see sections 4.3 and 5.2.
Arimidex has not been investigated in breast cancer patients with moderate or severe hepatic impairment.
Kivexa is not recommended in patients with moderate or severe hepatic impairment see sections 4.2 and 5.2.
Therefore, naloxegol has not been studied in OIC patients with moderate or severe hepatic impairment.
See also
Ceritinib is not recommended in patients with moderate or severe hepatic impairment see section 4.2.
Cannabidiol should be used with caution in patients with moderate or severe hepatic impairment.
KEYTRUDA has not been studied in patients with moderate or severe hepatic impairment see section 5.2.
There is no PK information available in patients with moderate or severe hepatic impairment.
Domperidone is contraindicated in patients with moderate or severe hepatic impairment ( see section 4.3 ).
No information is available for patients with moderate or severe hepatic impairment.
Possia has not been studied in patients with moderate or severe hepatic impairment.
Cemiplimab has not been studied in patients with moderate or severe hepatic impairment.
Use of temsirolimus in patients with MCL with moderate or severe hepatic impairment.
Table 1, Dose adjustments in patients with moderate or severe hepatic impairment.
Pembrolizumab has not been studied in patients with moderate or severe hepatic impairment ( see section 4.2 ).
Limited data are available for patients with moderate or severe hepatic impairment ( see section 4.2 ).
Tecentriq has not been studied in patients with moderate or severe hepatic impairment ( see section 5.2 ).
You'll also be interested in:
Examples of using Hepatic
Show more
Progressive renal or hepatic end organ dysfunction
Hepatic toxicity has been associated with acetaminophen
Monitoring of the hepatic function is also recommended
Examples of using Severe
Show more
This place has a severe tonal problem
Severe thermal burns can occur on contact
There are mild and severe cases of frostbite
Examples of using Moderate
Show more
There are moderate to large amounts of ketones in urine
Most undesirable effects were mild to moderate in severity
Exert only moderate pressure on the workpi
